DE1494846U - - Google Patents

Info

Publication number
DE1494846U
DE1494846U DENDAT1494846D DE1494846DU DE1494846U DE 1494846 U DE1494846 U DE 1494846U DE NDAT1494846 D DENDAT1494846 D DE NDAT1494846D DE 1494846D U DE1494846D U DE 1494846DU DE 1494846 U DE1494846 U DE 1494846U
Authority
DE
Germany
Prior art keywords
nmh
wich
nad
serves
ähoraoaame
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1494846D
Other languages
German (de)
English (en)
Publication of DE1494846U publication Critical patent/DE1494846U/de
Active legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DENDAT1494846D Active DE1494846U (enExample)

Publications (1)

Publication Number Publication Date
DE1494846U true DE1494846U (enExample)

Family

ID=799279

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1494846D Active DE1494846U (enExample)

Country Status (1)

Country Link
DE (1) DE1494846U (enExample)

Similar Documents

Publication Publication Date Title
MY124695A (en) Novel composition and use.
LU90865I2 (fr) Hydrochlorure d sibutramine ses d-riv-s et ses sels pharmaceutiquement acceptables en particulier le monohydrate d'hydrochlorure de sibutramine
RU97119646A (ru) Способы и составы для модулирования сексуальной реакции человека
EP1123087A4 (en) ORAL SYSTEM FOR THE ADMINISTRATION OF PULSED DOSES OF A MEDICAMENT
SI1638539T1 (sl) FARMACEVTSKI SESTAVKI, KI VSEBUJEJO pH OBÄŚUTLJIVE BLOK KOPOLIMERE IN HIDROFOBNO ZDRAVILNO UÄŚINKOVINO
GEP20043290B (en) Anti-Estrogen Plus Progestin Containing Oral Contraceptives
ATE346628T1 (de) Injektionssystem für die applikation halbfester, depotförmiger pharmazeutischer zusammensetzungen aus gelierbaren peptidsalzen
CA2417255A1 (en) Medicament comprising amrubicin and an anti-her2 antibody for treating breast cancer
IL147852A0 (en) Chemokine receptor antagonists and pharmaceutical compositions containing the same
DE1494846U (enExample)
GEP20043162B (en) Derivatives of Isosorbid Mononitrate, Utilization as Vasodilator Agents with Reduced Tolerance
MY124465A (en) Reduction of infarct volume using citicoline
GB1453034A (en) Pharmaceutical composition for treating spasticity
ES2156996T3 (es) Pieza añadida para un sujetador.
ZA955366B (en) Protective clothing especially antiballistic protective clothing for women
CA2285463A1 (en) A combination therapy for hiv infections
PL323305A1 (en) Applications of allyl amines
FR2547730B1 (fr) Medicament hypolipidemiant contenant comme ingredient actif la d-3-acetoxy-cis-2,3-dihydro-5-(2-(dimethylamino)ethyl)-2-(p-methoxyphenyl)-1,5-benzothiazepine-4(5h)-one ou un de ses sels d'addition d'acides acceptables en pharmacie
HUT74434A (en) Oral dosage form containing colestipol as a carrier and acidic substances and a process for producing the same
EE04176B1 (et) Selegiliini kasutamine epileptiliste haiguste raviks mõeldud ravimpreparaatide valmistamiseks
ATE66816T1 (de) Zusammensetzung fuer die bereitung eines arzneimittels zur topischen behandlung paradentaler krankheiten.
ATE386515T1 (de) Pharmazeutische zusammensetzung für die intrazelluläre ansäuerung mit cis-urocansäure
Scholz Some historical aspects of the development of cardiovascular drugs
ZA836127B (en) Spiro(2h-1,4-benzodioxepin-3(5h)4'-piperidine and-3-pyrrolidine)compounds,a process for preparing the same and their use as medicaments
TH21227A (th) การใช้ซีลีจิลีนสำหรับการรักษาความผิดปกติของโรคลมบ้าหมู